Barclays’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.4M | Sell |
254,100
-30,000
| -11% | -$4.2M | 0.01% | 855 |
|
|
2025
Q4 | $34.9M | Hold |
284,100
| – | – | 0.01% | 948 |
|
|
2025
Q3 | $31.5M | Sell |
284,100
-49,400
| -15% | -$5.62M | 0.01% | 991 |
|
|
2025
Q2 | $37M | Buy |
333,500
+200,900
| +152% | +$21.4M | 0.01% | 839 |
|
|
2025
Q1 | $14.9M | Buy |
132,600
+5,000
| +4% | +$516K | ﹤0.01% | 1173 |
|
|
2024
Q4 | $11.8M | Hold |
127,600
| – | – | ﹤0.01% | 1454 |
|
|
2024
Q3 | $10.7M | Buy |
+127,600
| New | +$9.74M | ﹤0.01% | 1442 |
|
|
2024
Q2 | – | Sell |
-126,400
| Closed | -$9.26M | – | 5034 |
|
|
2024
Q1 | $9.26M | Sell |
126,400
-75,600
| -37% | -$5.81M | ﹤0.01% | 1449 |
|
|
2023
Q4 | $16.4M | Sell |
202,000
-128,600
| -39% | -$10M | 0.01% | 1161 |
|
|
2023
Q3 | $24.8M | Sell |
330,600
-117,600
| -26% | -$9.05M | 0.02% | 695 |
|
|
2023
Q2 | $34.5M | Buy |
448,200
+200,600
| +81% | +$16M | 0.02% | 569 |
|
|
2023
Q1 | $20.5M | Buy |
+247,600
| New | +$20.5M | 0.01% | 830 |
|
|
2022
Q1 | – | Sell |
-1,001,400
| Closed | -$72.7M | – | 5196 |
|
|
2021
Q4 | $72.7M | Buy |
1,001,400
+486,400
| +94% | +$33.5M | 0.03% | 445 |
|
|
2021
Q3 | $36M | Buy |
515,000
+170,000
| +49% | +$11.9M | 0.02% | 658 |
|
|
2021
Q2 | $23.8M | Buy |
345,000
+315,000
| +1,050% | +$21M | 0.01% | 806 |
|
|
2021
Q1 | $1.94M | Sell |
30,000
-78,200
| -72% | -$5.04M | ﹤0.01% | 2301 |
|
|
2020
Q4 | $6.3M | Hold |
108,200
| – | – | ﹤0.01% | 1383 |
|
|
2020
Q3 | $6.84M | Sell |
108,200
-1,600
| -1% | -$111K | ﹤0.01% | 1219 |
|
|
2020
Q2 | $8.45M | Sell |
109,800
-677,500
| -86% | -$51.9M | 0.01% | 1057 |
|
|
2020
Q1 | $58.9M | Buy |
787,300
+189,900
| +32% | +$13.1M | 0.05% | 275 |
|
|
2019
Q4 | $38.8M | Buy |
597,400
+32,600
| +6% | +$2.12M | 0.02% | 613 |
|
|
2019
Q3 | $35.8M | Buy |
564,800
+162,100
| +40% | +$10.6M | 0.02% | 584 |
|
|
2019
Q2 | $27.2M | Sell |
402,700
-143,600
| -26% | -$9.45M | 0.02% | 760 |
|
|
2019
Q1 | $35.5M | Sell |
546,300
-107,600
| -16% | -$7.15M | 0.02% | 558 |
|
|
2018
Q4 | $40.9M | Sell |
653,900
-182,500
| -22% | -$12.8M | 0.03% | 450 |
|
|
2018
Q3 | $64.6M | Buy |
836,400
+165,800
| +25% | +$12.5M | 0.04% | 320 |
|
|
2018
Q2 | $47.5M | Buy |
670,600
+126,700
| +23% | +$8.95M | 0.04% | 373 |
|
|
2018
Q1 | $41M | Sell |
543,900
-548,500
| -50% | -$43.6M | 0.03% | 504 |
|
|
2017
Q4 | $78.3M | Buy |
1,092,400
+139,600
| +15% | +$10.6M | 0.06% | 249 |
|
|
2017
Q3 | $77.2M | Buy |
952,800
+630,200
| +195% | +$48.2M | 0.08% | 201 |
|
|
2017
Q2 | $22.8M | Sell |
322,600
-513,000
| -61% | -$34.1M | 0.02% | 547 |
|
|
2017
Q1 | $56.8M | Sell |
835,600
-332,700
| -28% | -$23.4M | 0.06% | 221 |
|
|
2016
Q4 | $83.7M | Sell |
1,168,300
-68,600
| -6% | -$5.1M | 0.09% | 172 |
|
|
2016
Q3 | $97.9M | Buy |
1,236,900
+233,100
| +23% | +$18.9M | 0.11% | 141 |
|
|
2016
Q2 | $83.7M | Buy |
1,003,800
+366,400
| +57% | +$32.5M | 0.11% | 144 |
|
|
2016
Q1 | $58M | Sell |
637,400
-1,094,900
| -63% | -$98.7M | 0.09% | 182 |
|
|
2015
Q4 | $175M | Sell |
1,732,300
-1,821,600
| -51% | -$190M | 0.21% | 78 |
|
|
2015
Q3 | $348M | Buy |
3,553,900
+248,200
| +8% | +$27.6M | 0.42% | 27 |
|
|
2015
Q2 | $387M | Sell |
3,305,700
-1,246,100
| -27% | -$136M | 0.43% | 23 |
|
|
2015
Q1 | $446M | Buy |
4,551,800
+253,600
| +6% | +$25.8M | 0.51% | 18 |
|
|
2014
Q4 | $404M | Buy |
4,298,200
+149,800
| +4% | +$15.5M | 0.39% | 27 |
|
|
2014
Q3 | $440M | Buy |
4,148,400
+976,900
| +31% | +$95.7M | 0.42% | 28 |
|
|
2014
Q2 | $260M | Sell |
3,171,500
-412,400
| -12% | -$32.1M | 0.28% | 46 |
|
|
2014
Q1 | $251M | Buy |
3,583,900
+3,113,300
| +662% | +$244M | 0.28% | 48 |
|
|
2013
Q4 | $35.3M | Sell |
470,600
-730,200
| -61% | -$50.8M | 0.04% | 480 |
|
|
2013
Q3 | $74.4M | Buy |
1,200,800
+934,800
| +351% | +$55.9M | 0.09% | 189 |
|
|
2013
Q2 | $13.6M | Buy |
+266,000
| New | +$13.9M | 0.02% | 862 |
|
Other funds holding GILD
VCM
VPM
Barclays's GILD Position: Q1 2026 in Review
Barclays reduced its Gilead Sciences (GILD) stake by 42% in Q1 2026, selling an estimated $537M and leaving 5,282,196 shares worth $736M. The position accounts for 0.18% of the portfolio, ranked #85.
Barclays first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12B in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Barclays held 5,282,196 shares of Gilead Sciences worth $736M as of Q1 2026.
- Barclays sold 3,833,287 Gilead Sciences shares in Q1 2026, an estimated $537M.
- Gilead Sciences made up 0.18% of Barclays's portfolio in Q1 2026, its #85 holding.
- Barclays first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Barclays's Gilead Sciences position peaked at $1.12B in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.